Roche

ROCHE NEWSROOM (893 press releases)

Advanced Filtering & Sorting Options:

Roche’s new medicine Erivedge received conditional EU approval for treatment of people with disfiguring and potentially life-threatening form of skin cancer

PRESS RELEASE -- 19, July 2013

Erivedge is a new medicine that helps people with a disfiguring and potentially life-threatening form of skin cancer 19-7-2013 — /europawire.eu/ — Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the European Commission has granted conditional approval to Erivedge (vismodegib) … Read the full press release

Roche launches Elecsys ProGRP test that distinguishes the two main types of lung cancer

PRESS RELEASE -- 19, July 2013

New test expands cancer diagnostics portfolio and strengthens Roche Diagnostics’ comprehensive tumour marker menu 19-7-2013 — /europawire.eu/ — Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the global launch (except US) of Elecsys ProGRP, a test that distinguishes between the two … Read the full press release

Roche launched two new highly sensitive therapeutic drug monitoring tests for the immunosuppressant medicines tacrolimus and cyclosporine

PRESS RELEASE -- 19, July 2013

Tests support long-term routine management of organ transplant recipients and enhanced workflow in medical labs 19-7-2013 — /europawire.eu/ —  Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the global launch (except US) of two new highly sensitive therapeutic drug monitoring … Read the full press release

EIB to lend EUR 15 billion to SMEs during 2013 to 2015 in order to support growth and jobs in Europe

PRESS RELEASE -- 16, May 2013

EIB attaches high importance to small and medium-sized enterprises 16-5-2013 — /europawire.eu/ — The European Investment Bank (EIB) attaches the highest importance to supporting small and medium-sized enterprises in order to promote growth and jobs in Europe. The President of the … Read the full press release

EU approval for Roche’s Pegasys

PRESS RELEASE -- 4, April 2013

Roche’s Pegasys receives EU approval for the treatment of chronic hepatitis C in children five years of age and older Basel, 4-4-2013 — /europawire.eu/ — Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the European Medicines Agency (EMA) has expanded the … Read the full press release

New Roche test to evaluate response to hepatitis C therapy approved by the FDA

PRESS RELEASE -- 3, April 2013

Viral load test uses a novel dual-probe approach designed to manage patients being treated with antiviral therapies Basel, 3-4-2013 — /europawire.eu/ — Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received approval from the US Food and Drug Administration … Read the full press release

Franz B. Humer, Chairman of the Board of Directors of the Roche Group, announced he will not stand for re-election in 2014

PRESS RELEASE -- 3, April 2013

Roche to inform about plans for succession in autumn 2013 3-4-2013 — /europawire.eu/ — Franz B. Humer, Chairman of the Board of Directors of the Roche Group, announced at today’s Annual General Meeting that he will not stand for re-election to … Read the full press release